Emergent Biosolutions, Inc.
XNYS:EBS
11.16
$13.21 - 100.00
$9.31 - 100.00
$11.11
$11.3
$11.22
$11.05
13.41
4.02
285556
852453.4
50444094.48
Chart
TendieTensor AI Analysis
Company
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Fundamentals
900
8.632148
1.010570
100
BBG000GW06J7
BBG001SP1G40
53.35M
52.52M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own EBS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.